switching from tirzepatide to retatrutide dosage vs Tirzepatide: the weight loss stats: , Tirzepatide- 22.5% in 72 weeks at 15mg (max dose) , Retatrutide- 28.7% in 68 weeks at 12mg (max dose) , Doesn't it make sense start the drug The GLP-1s-Semaglutide, Tirzepatide & Retatrutide:

J.SenguptaR.RichterM.DorseyJ

Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes

Vascular Function: Weight loss and metabolic improvements enhance endothelial functionthe ability of blood vessels to dilate properly

At a glance Target population / adult women aged 18+, BMI 30 or BMI 27 with comorbidity Primary medications / semaglutide (Wegovy/Ozempic-class) and tirzepatide (Zepbound/Mounjaro-class) Business model / cash-pay telehealth

Principal Scientist, Regeneron, Jay Caplan, President and Founder, Fractyl Health, Jerry Colca, Chief Scientific Officer, Cirius Therapeutics, Johan Fredrik Paulsson, Director Incretin and Amylin Biology, Novo Nordisk, Mina Sooch, Founder and General Partner, Apjohn Ventures, Scott Harris, Chief Medical Officer, Altimmune, Zohar Barbash, Chief Technology Officer, Lembas Bio Saturday, Aug 01, 2026 10:00a Atlantic Wharf Saturday, Jul 25, 2026 goes until 07/26 Davis Square Plaza Thursday, Jul 30, 2026 7:30p The Comedy Studio Saturday, Aug 01, 2026 6:00p John F

In the randomized controlled trial (RCT) by Kelly et al